𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antitumor effect of locally injected low doses of recombinant human interleukin-2 in bovine vulval papilloma and carcinoma

✍ Scribed by F.W.G. Hill; W.R. Klein; M.J. Hoyer; V.P.M.G. Rutten; N. Kock; J.W. Koten; P.A. Steerenberg; E.J. Ruitenberg; W. Den Otter

Book ID
119100293
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
629 KB
Volume
41
Category
Article
ISSN
0165-2427

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The synergistic antitumor effect of reco
The synergistic antitumor effect of recombinant interleukin-1 and low-dose of cyclophosphamide in tumor-bearing mice
✍ Takehisa Harada; Norimichi Kan; You Ichinose; Yoshio Moriguchi; Li Li; Tomoharu πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 631 KB

## Abstract Intraperitoneal (i. p.) treatment of MOPC104E ascitic tumor‐bearing BALB/c mice with interleukin‐1 (IL‐1) followed by a low dose of cyclophosphamide (CPA) resulted in synergistic prolongation of their survival time. This antitumor effect was abolished when administration of CPA preceded

Anti-tumor effects of local irradiation
Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2)
✍ I.-M. JΓΌrgenliemk-Schulz; I.B. Renes; D.H. Rutgers; L.A. Everse; M.R. Bernsen; W πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

The aim of this work was to improve radiotherapy results by immune stimulation. We tested the effects of a combination of radio-and immunotherapy, i.e., local low dose recombinant interleukin-2 (rIL-2) treatment, in two murine tumor models. Syngeneic tumors (SL2 lymphoma or M8013 mammary carcinoma)